No abstract available
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / genetics
-
Adenocarcinoma / immunology
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Antineoplastic Agents, Immunological / therapeutic use*
-
Chemotherapy, Adjuvant
-
Colorectal Neoplasms, Hereditary Nonpolyposis / genetics*
-
Fatal Outcome
-
Humans
-
Male
-
Middle Aged
-
Neoadjuvant Therapy*
-
Pancreatic Neoplasms / drug therapy*
-
Pancreatic Neoplasms / genetics
-
Pancreatic Neoplasms / immunology
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
pembrolizumab